BIO-RECELL LTD

12409412
Active United Kingdom

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
B

BIO-RECELL LTD

12409412

Research and experimental development on biotechnology

Founded 17 Jan 2020 Active United Kingdom 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 23 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 13 Apr 2026 Next due 14 Apr 2027 10 months remaining
Net assets £-793K £3M 2024 year on year
Total assets £9M £1M 2024 year on year
Total Liabilities £10M £4M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Website

www.example.com

Full company profile for BIO-RECELL LTD (12409412), an active life sciences and medical technology company based in United Kingdom. Incorporated 17 Jan 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 30 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£92.84k

Increased by £90.64k (+4109%)

Net Assets

-£792.92k

Decreased by £2.99M (-136%)

Total Liabilities

£9.92M

Increased by £4.07M (+70%)

Turnover

N/A

Employees

3

Debt Ratio

109%

Increased by 36 (+49%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Arko, Zoran, Mr.DirectorSlovenianSlovenia6217 Jan 2020Active
Skoberne, AlesDirectorSlovenianSlovenia5014 Feb 2020Active

Shareholders

Shareholders (3)

Zsbcell Ltd
57.0%
Elements Credit Opportunities I.
32.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Zsbcell Ltd

United Kingdom

Active
Notified 17 Jan 2020
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent

Group Structure

Group Structure

ZSBCELL LTD united kingdom
BIO-RECELL LTD Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Apr 2026Confirmation StatementConfirmation statement made on 31 Mar 2026 with no updates
30 Mar 2026OfficersChange to director Mr Nader Bawany on 1 Mar 2026
23 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
31 Mar 2025OfficersChange to director Ales Skoberne on 28 Mar 2025
31 Mar 2025Confirmation StatementConfirmation statement made on 31 Mar 2025 with no updates
13 Apr 2026 Confirmation Statement

Confirmation statement made on 31 Mar 2026 with no updates

30 Mar 2026 Officers

Change to director Mr Nader Bawany on 1 Mar 2026

23 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

31 Mar 2025 Officers

Change to director Ales Skoberne on 28 Mar 2025

31 Mar 2025 Confirmation Statement

Confirmation statement made on 31 Mar 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 31 Mar 2026 with no updates

2 months ago on 13 Apr 2026

Change to director Mr Nader Bawany on 1 Mar 2026

2 months ago on 30 Mar 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 23 Sept 2025

Change to director Ales Skoberne on 28 Mar 2025

1 years ago on 31 Mar 2025

Confirmation statement made on 31 Mar 2025 with no updates

1 years ago on 31 Mar 2025